Published in Cancer Treat Rev on August 01, 2002
Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. J Clin Oncol (2005) 7.57
Prospective medical assessment of adults surviving childhood cancer: study design, cohort characteristics, and feasibility of the St. Jude Lifetime Cohort study. Pediatr Blood Cancer (2010) 2.69
The epidemiology of arm and hand swelling in premenopausal breast cancer survivors. Cancer Epidemiol Biomarkers Prev (2007) 2.25
Cardiovascular risk factors in adult survivors of pediatric cancer--a report from the childhood cancer survivor study. Cancer Epidemiol Biomarkers Prev (2010) 1.61
High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation. Bone Marrow Transplant (2008) 1.27
Cancer survivorship care: exploring the role of the general internist. J Gen Intern Med (2009) 1.06
Body composition abnormalities in long-term survivors of pediatric hematopoietic stem cell transplantation. J Pediatr (2011) 0.96
Long-term consequences of hematopoietic stem cell transplantation: current state of the science. Biol Blood Marrow Transplant (2009) 0.87
Detection of metabolic syndrome features among childhood cancer survivors: a target to prevent disease. Vasc Health Risk Manag (2008) 0.84
Impact of treatment exposures on cardiovascular risk and insulin resistance in childhood cancer survivors. Cancer Epidemiol Biomarkers Prev (2013) 0.83
Long-term Toxicity of Cancer Treatment in Older Patients. Clin Geriatr Med (2015) 0.83
Exercise after diagnosis and metabolic syndrome among breast cancer survivors: a report from the Shanghai Breast Cancer Survival Study. Cancer Causes Control (2013) 0.80
Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy. Support Care Cancer (2006) 0.80
Randomized controlled trial to evaluate the effects of combined progressive exercise on metabolic syndrome in breast cancer survivors: rationale, design, and methods. BMC Cancer (2014) 0.80
Abnormal adipose tissue distribution with unfavorable metabolic profile in five children following hematopoietic stem cell transplantation: a new etiology for acquired partial lipodystrophy. Clin Pediatr Endocrinol (2013) 0.77
Premature Atherosclerotic Cardiovascular Disease in Childhood Cancer Survivors. Prog Pediatr Cardiol (2015) 0.75
Comparison of diabetes management status between cancer survivors and the general population: results from a Korean population-based survey. PLoS One (2014) 0.75
Racial differences in dietary changes and quality of life after a colorectal cancer diagnosis: a follow-up of the Study of Outcomes in Colorectal Cancer Survivors cohort. Am J Clin Nutr (2016) 0.75
Health knowledge about symptoms of heart attack and stroke in adult survivors of childhood acute lymphoblastic leukemia. Ann Epidemiol (2007) 0.75
Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer. J Clin Oncol (2005) 3.29
Metformin: taking away the candy for cancer? Eur J Cancer (2010) 2.68
Treatment-specific risks of second malignancies and cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2007) 2.68
Association between increased arterial-wall thickness and impairment in ABCA1-driven cholesterol efflux: an observational study. Lancet (2002) 2.39
Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension (2007) 2.33
Measurement of arterial wall thickness as a surrogate marker for atherosclerosis. Circulation (2004) 1.98
The metabolic syndrome in cancer survivors. Lancet Oncol (2010) 1.93
The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer. J Clin Oncol (2005) 1.88
Bevacizumab-induced normalization of blood vessels in tumors hampers antibody uptake. Cancer Res (2013) 1.87
Imatinib mesylate for the treatment of gastrointestinal stromal tumours: best monitored with FDG PET. Nucl Med Commun (2004) 1.84
Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients. J Am Soc Nephrol (2005) 1.82
Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study. Lancet Oncol (2008) 1.80
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Skin autofluorescence is a strong predictor of cardiac mortality in diabetes. Diabetes Care (2007) 1.73
Effect of an increased intake of alpha-linolenic acid and group nutritional education on cardiovascular risk factors: the Mediterranean Alpha-linolenic Enriched Groningen Dietary Intervention (MARGARIN) study. Am J Clin Nutr (2002) 1.63
Variation in bleomycin hydrolase gene is associated with reduced survival after chemotherapy for testicular germ cell cancer. J Clin Oncol (2008) 1.63
Feasibility of withholding antibiotics in selected febrile neutropenic cancer patients. J Clin Oncol (2005) 1.62
Skin autofluorescence: a tool to identify type 2 diabetic patients at risk for developing microvascular complications. Diabetes Care (2007) 1.59
Cardiovascular toxicity caused by cancer treatment: strategies for early detection. Lancet Oncol (2009) 1.58
Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care (2006) 1.58
Indium-111-labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer. J Clin Oncol (2006) 1.57
Long-term risk of cardiovascular disease in 5-year survivors of testicular cancer. J Clin Oncol (2006) 1.55
Prevalence and persistence of masked hypertension in treated hypertensive patients. Am J Hypertens (2007) 1.50
Prevalence of the white-coat effect at multiple visits before and during treatment. J Hypertens (2006) 1.48
Vascular thoracic outlet syndrome. Longer posterior rib stump causes poor outcome. Eur J Cardiothorac Surg (2006) 1.45
Cytoplasmic p21 expression levels determine cisplatin resistance in human testicular cancer. J Clin Invest (2010) 1.43
Validation of serum amyloid α as an independent biomarker for progression-free and overall survival in metastatic renal cell cancer patients. Eur Urol (2012) 1.41
The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress. Cardiovasc Drugs Ther (2007) 1.41
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy. Int J Radiat Oncol Biol Phys (2009) 1.36
VEGF-PET imaging is a noninvasive biomarker showing differential changes in the tumor during sunitinib treatment. Cancer Res (2010) 1.27
Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol (2012) 1.26
Clinical evaluation of M30 and M65 ELISA cell death assays as circulating biomarkers in a drug-sensitive tumor, testicular cancer. Neoplasia (2008) 1.25
Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications. Eur J Heart Fail (2007) 1.20
Serum 25-hydroxyvitamin D concentration in subclinical carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 1.18
Skin autofluorescence, a novel marker for glycemic and oxidative stress-derived advanced glycation endproducts: an overview of current clinical studies, evidence, and limitations. Diabetes Technol Ther (2006) 1.18
Cross-sectional analysis of baseline data to identify the major determinants of carotid intima-media thickness in a European population: the IMPROVE study. Eur Heart J (2009) 1.17
Mapatumumab, a fully human agonistic monoclonal antibody that targets TRAIL-R1, in combination with gemcitabine and cisplatin: a phase I study. Clin Cancer Res (2009) 1.16
Back to basics in diagnosing diabetic polyneuropathy with the tuning fork! Diabetes Care (2005) 1.15
Vascular damage in testicular cancer patients: a study on endothelial activation by bleomycin and cisplatin in vitro. Oncol Rep (2010) 1.15
Apolipoprotein(a) genetic sequence variants associated with systemic atherosclerosis and coronary atherosclerotic burden but not with venous thromboembolism. J Am Coll Cardiol (2012) 1.14
Translating TRAIL-receptor targeting agents to the clinic. Cancer Lett (2012) 1.10
Local differences in skin autofluorescence may not reflect similar differences in oxidative stress exposure. J Rheumatol (2013) 1.09
Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10). PLoS One (2009) 1.06
Preventing weight gain: one-year results of a randomized lifestyle intervention. Am J Prev Med (2009) 1.04
The optimal scheme of self blood pressure measurement as determined from ambulatory blood pressure recordings. J Hypertens (2006) 1.04
Early atherosclerosis in systemic sclerosis and its relation to disease or traditional risk factors. Arthritis Res Ther (2008) 1.00
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease. Arterioscler Thromb Vasc Biol (2012) 0.99
Is glycogen storage disease 1a associated with atherosclerosis? Eur J Pediatr (2002) 0.98
Educational needs of general practitioners in palliative care: outcome of a focus group study. J Cancer Educ (2005) 0.98
Skin autofluorescence is elevated in patients with stable coronary artery disease and is associated with serum levels of neopterin and the soluble receptor for advanced glycation end products. Atherosclerosis (2007) 0.98
Carotid artery intima media thickness associates with skin autofluoresence in non-diabetic subjects without clinically manifest cardiovascular disease. Eur J Clin Invest (2010) 0.98
Marital and sexual satisfaction in testicular cancer survivors and their spouses. Support Care Cancer (2005) 0.97
Preventing weight gain by lifestyle intervention in a general practice setting: three-year results of a randomized controlled trial. Arch Intern Med (2011) 0.97
Tumor necrosis factor-related apoptosis-inducing ligand pathway and its therapeutic implications. Clin Cancer Res (2006) 0.96
Phase I safety, pharmacokinetic, and pharmacodynamic study of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 in patients with advanced cancer. J Clin Oncol (2005) 0.96
The effect of exercise counselling with feedback from a pedometer on fatigue in adult survivors of childhood cancer: a pilot study. Support Care Cancer (2008) 0.96
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease. Arterioscler Thromb Vasc Biol (2014) 0.95
Clinical and prognostic value of advanced glycation end-products in chronic heart failure. Eur Heart J (2007) 0.95
Skin color independent assessment of aging using skin autofluorescence. Opt Express (2010) 0.95
Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler Thromb Vasc Biol (2013) 0.95
Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol (2005) 0.95
Placental site trophoblastic tumor in a late recurrence of a nonseminomatous germ cell tumor of the testis. Am J Surg Pathol (2004) 0.95
Clinical diagnosis of diabetic polyneuropathy with the diabetic neuropathy symptom and diabetic neuropathy examination scores. Diabetes Care (2003) 0.95
Dermal factors influencing measurement of skin autofluorescence. Diabetes Technol Ther (2011) 0.92
Identification of the BCAR1-CFDP1-TMEM170A locus as a determinant of carotid intima-media thickness and coronary artery disease risk. Circ Cardiovasc Genet (2012) 0.92
Non-germ cell malignancy in residual or recurrent mass after chemotherapy for nonseminomatous testicular germ cell tumor. Ann Surg Oncol (2003) 0.92
Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patients. Intensive Care Med (2003) 0.92
Increased intima-media thickness after early-onset preeclampsia. Obstet Gynecol (2006) 0.92
Sexual function, depressive symptoms and marital status in nonseminoma testicular cancer patients: a longitudinal study. Psychooncology (2010) 0.91
Serum HER2 levels are increased in patients with chronic heart failure. Eur J Heart Fail (2006) 0.91
The willingness of general practitioners to be involved in the follow-up of adult survivors of childhood cancer. J Cancer Surviv (2007) 0.91
Effects of amlodipine and lisinopril on intima-media thickness in previously untreated, elderly hypertensive patients (the ELVERA trial). J Hypertens (2004) 0.91
Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease. Arthritis Res Ther (2011) 0.91
Systolic and diastolic dysfunction in long-term adult survivors of childhood cancer. Eur J Cancer (2011) 0.91
AGE and their receptor RAGE in systemic autoimmune diseases: an inflammation propagating factor contributing to accelerated atherosclerosis. Autoimmunity (2009) 0.91
Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease. Ann N Y Acad Sci (2005) 0.91
Circulating apoptotic proteins are increased in long-term disease-free breast cancer survivors. Acta Oncol (2006) 0.91
AGEs, autofluorescence and renal function. Nephrol Dial Transplant (2008) 0.91
Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients. J Card Fail (2008) 0.90
Male sexuality after cancer treatment--needs for information and support: testicular cancer compared to malignant lymphoma. Patient Educ Couns (2004) 0.90
Accumulation of advanced glycation end products and chronic complications in ESRD treated by dialysis. Am J Kidney Dis (2008) 0.89
Easy navigating through the forest of survivorship care. J Clin Oncol (2013) 0.89
Randomized controlled trial on cardiovascular risk management by practice nurses supported by self-monitoring in primary care. BMC Fam Pract (2012) 0.89
Endothelial damage in long-term survivors of childhood cancer. J Clin Oncol (2013) 0.89
Longitudinal study on premature atherosclerosis in patients with systemic lupus erythematosus. Atherosclerosis (2009) 0.88
Endothelial dysfunction in patients with coronary artery disease: a comparison of three frequently reported tests. J Investig Med (2002) 0.88
Advanced glycation end-products and skin autofluorescence in end-stage renal disease: a review. Clin Chem Lab Med (2014) 0.88
Safety, pharmacokinetics, and pharmacodynamics of the DR5 antibody LBY135 alone and in combination with capecitabine in patients with advanced solid tumors. Invest New Drugs (2013) 0.87
Self-esteem, social support, and mental health in survivors of testicular cancer: a comparison based on relationship status. Urol Oncol (2006) 0.87